ABCC8 Single Nucleotide Polymorphisms are Associated with Cerebral Edema in Severe TBI
- 27 September 2016
- journal article
- research article
- Published by Springer Science and Business Media LLC in Neurocritical Care
- Vol. 26 (2), 213-224
- https://doi.org/10.1007/s12028-016-0309-z
Abstract
Objective Cerebral edema (CE) in traumatic brain injury (TBI) is the consequence of multiple underlying mechanisms and is associated with unfavorable outcomes. Genetic variability in these pathways likely explains some of the clinical heterogeneity observed in edema development. A role for sulfonylurea receptor-1 (Sur1) in CE is supported. However, there are no prior studies examining the effect of genetic variability in the Sur1 gene (ABCC8) on the development of CE. We hypothesize that ABCC8 single nucleotide polymorphisms (SNPs) are predictive of CE. Methods DNA was extracted from 385 patients. SNPs in ABCC8 were genotyped using the Human Core Exome v1.2 (Illumina). CE measurements included acute CT edema, mean and peak intracranial pressure (ICP), and need for decompressive craniotomy. Results Fourteen SNPs with minor allele frequency >0.2 were identified. Four SNPS rs2283261, rs3819521, rs2283258, and rs1799857 were associated with CE measures. In multiple regression models, homozygote-variant genotypes in rs2283261, rs3819521, and rs2283258 had increased odds of CT edema (OR 2.45, p = 0.007; OR 2.95, p = 0.025; OR 3.00, p = 0.013), had higher mean (β = 3.13, p = 0.000; β = 2.95, p = 0.005; β = 3.20, p = 0.008), and peak ICP (β = 8.00, p = 0.001; β = 7.64, p = 0.007; β = 6.89, p = 0.034). The homozygote wild-type genotype of rs1799857 had decreased odds of decompressive craniotomy (OR 0.47, p = 0.004). Conclusions This is the first report assessing the impact of ABCC8 genetic variability on CE development in TBI. Minor allele ABCC8 SNP genotypes had increased risk of CE, while major SNP alleles were protective—potentially suggesting an evolutionary advantage. These findings could guide risk stratification, treatment responders, and the development of novel targeted or gene-based therapies against CE in TBI and other neurological disorders.Keywords
Funding Information
- National Institutes of Health (KL2 TR000146, R00 NR013176, R01 NR013342)
This publication has 38 references indexed in Scilit:
- Mildly Reduced Brain Swelling and Improved Neurological Outcome in Aquaporin-4 Knockout Mice following Controlled Cortical Impact Brain InjuryJournal of Neurotrauma, 2015
- Deletion of aquaporin-4 is neuroprotective during the acute stage of micro traumatic brain injury in miceNeuroscience Letters, 2015
- AQP4 Tag Single Nucleotide Polymorphisms in Patients with Traumatic Brain InjuryJournal of Neurotrauma, 2014
- High mobility group box protein‐1 promotes cerebral edema after traumatic brain injury via activation of toll‐like receptor 4Glia, 2013
- Novel Treatment Targets for Cerebral EdemaNeurotherapeutics, 2012
- Glibenclamide Reduces Hippocampal Injury and Preserves Rapid Spatial Learning in a Model of Traumatic Brain InjuryJournal of Neuropathology and Experimental Neurology, 2010
- Genetic association studies in patients with traumatic brain injuryNeurosurgical Focus, 2010
- Key Role of Sulfonylurea Receptor 1 in Progressive Secondary Hemorrhage after Brain ContusionJournal of Neurotrauma, 2009
- Newly expressed SUR1-regulated NCCa-ATP channel mediates cerebral edema after ischemic strokeNature Medicine, 2006
- Intracranial pressure: to monitor or not to monitor?Journal of Neurosurgery, 1982